
CLEARONE INC
100
Recent developments include ClearOne's merger agreement with Vivani subsidiary Cortigent, ongoing financial challenges with wider losses and revenue declines, and Nasdaq listing compliance issues.
- On July 2, 2026, ClearOne entered into a merger agreement with Vivani subsidiary Cortigent, creating Nasdaq-listed Cortigent Holdings, subject to stockholder and regulatory approvals [N1].
- In August 2025, ClearOne reported a wider Q2 loss, revenue decline, and announced a plan to sell certain assets [N4].
- In May 2025, ClearOne's stock declined 27% after posting a wider Q1 loss and year-over-year revenue dip [N8].
- In April 2025, ClearOne reported a Q4 loss despite cost cuts and new product launches [N3].
- The company faces ongoing Nasdaq listing compliance challenges with a hearing scheduled for November 2026 [S2].
ClearOne, Inc. was historically engaged in the design, development, and marketing of professional audio conferencing, microphone, and video collaboration solutions. In October 2025, the company sold key operating assets to Biamp Systems, LLC, ceasing product manufacturing and sales. Post-sale, ClearOne's operations are limited to warranty servicing, asset management, and strategic evaluation. The company is actively pursuing strategic alternatives to enhance stockholder value, including a merger agreement with Vivani subsidiary Cortigent announced in July 2026. The merger is subject to multiple conditions including stockholder approvals and Nasdaq listing requirements. ClearOne faces liquidity constraints, a net loss in the latest quarter, and Nasdaq compliance risks. The company reincorporated from Delaware to Nevada in April 2026, affecting governance and stockholder rights.
ClearOne, Inc. transitioned from an operating company designing and marketing audio and video collaboration products to a transitional entity following an October 2025 asset sale. The company now focuses on warranty servicing, managing remaining assets and liabilities, and evaluating strategic alternatives including a merger with Vivani subsidiary Cortigent. As of September 30, 2026, ClearOne reported a net loss of $709,000, with limited liquidity and a current ratio below 1. The company faces Nasdaq listing compliance challenges and is subject to a pending hearing regarding potential delisting. The merger agreement with Cortigent, announced in July 2026, involves significant dilution and change of control. Risks include the ability to complete strategic transactions, maintain compliance, and manage legacy obligations. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
ClearOne's strategic shift through the asset sale and merger agreement with Cortigent reflects a transition from a legacy product company to a new operating entity with potential new business opportunities. The merger creates a Nasdaq-listed combined company with Vivani holding majority control, which may provide access to capital and operational resources. The company's active pursuit of strategic alternatives and ongoing warranty servicing obligations demonstrate a managed transition. Successful completion of the merger and financing could enable ClearOne to leverage new business lines and investor interest.
ClearOne faces significant challenges including limited liquidity, ongoing net losses, and a current ratio below 1, indicating potential short-term financial stress. The company is at risk of Nasdaq delisting due to non-compliance with listing standards, with a hearing pending. The merger agreement is subject to multiple conditions and may not close, which could leave ClearOne without an operating business and limited strategic alternatives. The substantial dilution and change of control may reduce existing stockholder influence. Legacy warranty obligations and reduced workforce may impair operational effectiveness and compliance.
ClearOne's historical moat was based on its proprietary audio and video collaboration technologies and product offerings. However, following the October 2025 asset sale and cessation of product manufacturing and sales, the company no longer operates in its prior competitive markets. Its current operations are transitional, focused on warranty servicing and strategic alternatives, which do not provide a sustainable competitive moat. The pending merger with Cortigent may create new business opportunities, but the combined entity's competitive positioning remains to be established.
• Strategic Transaction Completion Risk: ClearOne may be unable to complete the merger with Cortigent or other strategic transactions on attractive terms or at all, which could impair its ability to continue operations or improve liquidity [S1][S2].
• Liquidity and Going Concern Risk: The company has limited cash and current assets relative to liabilities, with a current ratio of 0.48 as of September 30, 2026, and has incurred significant losses, raising substantial doubt about its ability to continue as a going concern [S2].
• Nasdaq Listing Compliance Risk: ClearOne is not in compliance with Nasdaq listing standards, including minimum stockholders' equity, and faces potential delisting pending a hearing scheduled for November 17, 2026 [S2].
• Merger-Related Risks: The merger with Cortigent involves significant dilution, change of control, integration challenges, and contingent liabilities that may adversely affect the combined company's financial condition and operations [S2].
• Warranty and Legacy Obligations Risk: ClearOne continues to fulfill warranty and technical support obligations on legacy products, with uncertain ultimate costs that could adversely affect financial condition and liquidity [S1].
• Reduced Workforce and Operational Risk: Following asset disposition, ClearOne operates with a significantly reduced workforce, which may impair internal controls, compliance, and ability to manage obligations effectively [S1].
• Cybersecurity Risk: The company faces cybersecurity risks including potential breaches and limited internal IT resources, which could disrupt operations and expose it to regulatory and reputational harm [S1].
• Ownership Concentration Risk: ClearOne's largest stockholder holds majority voting power and consent rights, potentially limiting other stockholders' influence and affecting strategic decisions [S1].
Business trends: Transition from legacy product operations to strategic merger and warranty servicing with limited revenue generation.
Execution milestones: Completion of merger with Cortigent, Nasdaq listing compliance hearing, and successful integration of combined entity.
Key risks: Failure to complete merger or strategic transactions, liquidity constraints, Nasdaq delisting, legacy obligations, and operational challenges with reduced workforce.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- ClearOne, Inc. is a Delaware corporation that was previously engaged in designing, developing, and marketing professional audio conferencing, microphone, and video collaboration solutions [S1].
- In October 2025, ClearOne completed the sale of certain intellectual property, product inventory, and non-exclusive rights to customer data to Biamp Systems, LLC for $3.0 million [S1].
- Post-asset sale, ClearOne no longer manufactures or sells products and maintains limited inventory to service warranties; continuing activities include warranty and technical support on legacy products, managing remaining assets and liabilities, evaluating strategic transactions, and maintaining public company compliance [S1].
- The company is actively evaluating strategic alternatives including special transactions, investments, acquisitions, additional asset sales, or other actions to maximize stockholder value [S1].
- ClearOne's continuing activities are transitional and not expected to generate material revenue [S1].
- As of September 30, 2026, ClearOne had $18,000 in cash and cash equivalents, current assets of $610,000, current liabilities of $1,273,000, resulting in a current ratio of 0.48 and a cash ratio of 0.01 [S2].
- The company reported a net loss of $709,000 and basic and diluted EPS of -$0.26 for the quarter ended September 30, 2026 [S2].
- ClearOne received a Nasdaq notice of non-compliance due to insufficient stockholders' equity and is subject to potential delisting; a hearing is scheduled for November 17, 2026 [S2].
- ClearOne reincorporated from Delaware to Nevada in April 2026, which may affect stockholder rights and governance [S2].
- On July 1, 2026, ClearOne entered into a merger agreement with Vivani subsidiary Cortigent, creating a Nasdaq-listed Cortigent Holdings; completion is subject to stockholder approvals, financing, and Nasdaq listing requirements [N1][S2].
- The merger will result in substantial dilution of existing stockholders and a change of control, with Vivani holding majority voting power and designating key executives and directors [S2].
- ClearOne's largest stockholder beneficially owned approximately 61.3% of outstanding common stock as of March 16, 2026, with significant influence over corporate matters [S1].
- The company faces risks including the ability to complete strategic transactions, obtain financing, maintain Nasdaq listing, fulfill warranty obligations, and manage cybersecurity risks with a reduced workforce [S1][S2].
Generated 2026-11-11
- S1 | 2026-03-31 | 10-K
- S2 | 2026-11-10 | 10-Q
- N1 | 2026-07-02 | www.nasdaq.com | Vivani Subsidiary Cortigent To Merge With ClearOne, Creating Nasdaq-Listed Cortigent Holdings | https://www.nasdaq.com/articles/vivani-subsidiary-cortigent-merge-clearone-creating-nasdaq-listed-cortigent-holdings
- N2 | 2025-10-09 | www.nasdaq.com | The Zacks Analyst Blog Highlights SAP, Novartis, Philip Morris International, ImmuCell and ClearOne | https://www.nasdaq.com/articles/zacks-analyst-blog-highlights-sap-novartis-philip-morris-international-immucell-and
- N3 | 2025-10-08 | www.nasdaq.com | Top Stock Reports for SAP, Novartis & Philip Morris | https://www.nasdaq.com/articles/top-stock-reports-sap-novartis-philip-morris
- N4 | 2025-08-21 | www.nasdaq.com | ClearOne Stock Falls on Wider Q2 Loss, Revenue Decline and Sale Plan | https://www.nasdaq.com/articles/clearone-stock-falls-wider-q2-loss-revenue-decline-and-sale-plan
- N5 | 2025-08-18 | www.nasdaq.com | Stocks Moving Premarket: PPCB, BTAI, TNXP, DAY, TPIC, And Other Gainers & Losers | https://www.nasdaq.com/articles/stocks-moving-premarket-ppcb-btai-tnxp-day-tpic-and-other-gainers-losers
- N6 | 2025-07-29 | www.nasdaq.com | The Zacks Analyst Blog Highlights Microsoft, SAP, AMD, PrimeEnergy Resources and ClearOne | https://www.nasdaq.com/articles/zacks-analyst-blog-highlights-microsoft-sap-amd-primeenergy-resources-and-clearone
- N7 | 2025-07-28 | www.nasdaq.com | Top Stock Reports for Microsoft, SAP & AMD | https://www.nasdaq.com/articles/top-stock-reports-microsoft-sap-amd
- N8 | 2025-05-27 | www.nasdaq.com | ClearOne Stock Sinks 27% After Posting Wider Q1 Loss, Y/Y Revenue Dip | https://www.nasdaq.com/articles/clearone-stock-sinks-27-after-posting-wider-q1-loss-y-y-revenue-dip
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


